New study aims to simplify diagnosis of autoimmune platelet disorder

NCT ID NCT04800458

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a specialized blood test (MAIPA) can accurately identify autoimmune thrombocytopenia (ITP) in patients with low platelet counts. Currently, ITP is diagnosed by ruling out other causes, which can be slow and uncertain. Researchers will collect blood samples from 225 adults with low platelets to see if anti-platelet antibodies detected by MAIPA can confirm an autoimmune cause at diagnosis.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a more reliable diagnostic test for autoimmune thrombocytopenia, reducing misdiagnosis and unnecessary treatments.
What could go wrong
This is an observational study, not a treatment trial. It may not change current practice if the antibody test proves unreliable or impractical.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU de Bordeaux - service de médecine interne

    RECRUITING

    Pessac, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.